Introduction 27 28
Influenza virus is the major cause of severe viral respiratory infection in adults, resulting 29 in more than 200,000 hospitalizations and 30,000 to 50,000 deaths each year in the US 30
(1). A critical factor in influenza virus-associated morbidity and mortality is the increased 31 susceptibility of infected individuals to bacterial pneumonia, a common complication of 32 influenza pandemics (2, 3) and epidemics (4). Epidemiological studies have shown that 33 despite circulating in humans since 1968, seasonal H3N2 influenza outbreaks are 34 associated with increased clinical severity, including excess respiratory mortality and 35 excess pneumonia and influenza hospitalizations (5). During the 2014-2015 season, the 36 antigenically drifted H3N2 influenza virus caused major outbreaks globally, resulting in 37 increased pneumoniaand influenza-associated mortality 38
(http://www.cdc.gov/flu/weekly/weeklyarchives2014-2015/week2.htm#S2) (6). 39
Although annual trivalent influenza vaccines are available and widely received, vaccine 40 effectiveness can be limited. Vaccines are less effective in the elderly, a population that 41 is particularly vulnerable to influenza infections and that tends to develop more severe 42 influenza complications (7). In general, H3N2 influenza strains have been associated 43 with lower antibody responses and decreased vaccine effectiveness even in well-44 matched years (8, 9) . During the 2014-2015 influenza season, vaccine effectiveness in 45 the Northern Hemisphere against H3-specific influenza was estimated to be at 22% 46 (95% CI, 5-35%) (10). This low effectiveness was attributed both to the low 47
Comamonadaceae. NP-type C was dominated by Moraxella while NP-type D had an 141 overrepresentation of Staphylococcus. The different communities did not associate 142 differently with either of the flu types (IAV vs IBV) . 143
144

Association of vaccination with the nasopharynx microbiota is different in IAV 145
and IBV. 146
We determined whether vaccination in the current season had an association with the 147 microbial composition of the NP in the influenza-infected individuals. We did not 148 observe differences in sample clustering between individuals who were vaccinated or 149 not, indicating that microbial composition was similar in both groups (Fig 4a; p.value 150 >0.01 in AMOVA). However, when looking for taxonomic features that significantly 151 characterized each group, we observe by LEfSe analysis an enrichment of specific taxa 152 in the unvaccinated subjects-Moraxella in IAV (p=0.002), and Streptococcus in IBV 153 (p=0.010) (Fig. 4b) . 154
155
We also tested for age-dependent differences in the microbiota of the nasopharynx in 156 vaccinated and unvaccinated individuals infected with either IAV or IBV, but we did not 157 observe any significant differences in enriched taxa between age groups. However, 158 when testing overall microbial diversity (as measured by Shannon entropy), we observe 159 higher microbial diversity in the unvaccinated elderly than in the vaccinated elderly 160 (Wilcox test p.value = 0.005) (Fig. 5a) ; we did not observe a similar effect in the two 161 other age groups. To further study what compositional differences contributed to this 162 age-specific difference in microbial diversity, we identified with LEfSe 7 microbial taxafor which relative abundance was significantly higher in the unvaccinated elderly group 164 (Fig. 5b) . Some members of these taxa such as Staphylococcaceae, Gram-negative 165 bacteria (Pasteurellaceae and Escherichia/Shigella), and Sphingomonas also include 166 species known to be associated with post-influenza (including pneumonia) and 167 nosocomial infections (18). Finally, we tested if any of the clinical variables (listed in 168 Table 1 and Table S1 ), including pneumonia, antibiotic usage, Tamiflu usage, and 169 immunocompromise, was associated with specific features of the nasopharyngeal 170 microbiota, but we did not find any significant association. 171
172
Influenza genetic diversity affects the microbiota of the nasopharynx. 173
While we observed differences in microbial enrichment between individuals infected 174 with IAV and IBV, and in community types for infected versus controls, we explored 175 whether there was also an association between IAV genetic diversity and the microbial 176 community within the nasopharynx. We first performed a K-mer analysis to identify 177 underlying influenza sequence signatures for each sample and compared them to each 178 other, visualizing this measure of genetic distance by multidimensional scaling (Fig. 6a) . 179
Three clusters were identified for influenza A/H3N2, with 2 clusters corresponding to the 180 3C.2a genetic clade. While we did not see a correspondence between the sample 181 clustering profile and the NP-type microbial profiles (data not shown), we did observe by 182 performing LEfSe analysis that one of the two 3C.2a clusters, HA-2, had a significantly 183 higher relative abundance of Escherichia (Shigella) (Fig. 6b) 
217
In the analysis of community types, we saw that one type in particular (NP-type A) was 218 enriched in influenza-infected subjects and was comprised primarily of Dolosigranulum 219
and Streptococcus. We also identified a negative association between influenza 220 infection and Corynebacterium. Corynebacterium has been found to commonly colonize 221 the human nose and skin and was shown to be overrepresented in children free of 222 Streptococcus pneumoniae (27) . Corynebacterium accolens was shown to inhibit the 223 growth of S. pneumoniae by releasing antibacterial free fatty acids (27) Since our study was cross-sectional and we studied the composition of the nasopharynx 240 microbiota at the moment of diagnosis, we cannot determine whether differences 241 between healthy controls and influenza-infected individuals are due to the infection, due 242
to the presence of a microbial community that predisposes to infection, or a combination 243 can modify the microbiota of the nasal cavity (16), while a study where volunteers 248 challenged with an H3N2 strain were sampled over a 30-day period did not show any 249 changes in the oropharyngeal microbiota (21). This lack of an effect may be due to the 250 fact that the cohort was comprised of young and healthy volunteers with many who 251 developed very mild disease (19 out the 52 challenged individuals). In contrast, our 252 cohort includes patients from all age groups, including young and elderly, with a range 253 of disease severity. A recent household transmission study shows that influenza 254 susceptibility is associated with differences in the overall bacterial community structure, 255 with a particularly increased influenza risk in young children (20). These differences 256 between studies suggest that patient characteristics such as age, comorbidities, 257 vaccination status and treatments and viral characteristics need to be considered when 258 studying the effect of influenza infection on the respiratory microbiota. 259
260
Our study also addresses the association of vaccination with differences in the 261 microbiota of the nasopharynx during influenza infection. The effectiveness of the 262 influenza vaccine varies in different seasons (31, 32) due to a number of factors, such 263 as vaccine strain mismatch and host immune status, including history of previous 264 influenza vaccination. We suggest that another potential factor is the host microbiome. 265
Recent studies have shown that the human microbiota, by impacting immune cell 266 development and differentiation, could influence adjuvant and vaccine efficacy (33). 267 LAIV was shown to affect the microbiota of the nasopharynx (15, 16), and lead to an 268 increased abundance of specific microbes associated with IgA responses (15). A study 269 on the effects of trivalent LAIV on bacterial carriage in the nasopharynx of toddlers 270
showed that there was an increase in S. pneumonia and M. catarrhalis density 28 days 271 after vaccination (34), indicating that the influenza virus, even when attenuated, could 272 impact carriage density. 273
274
We show that in influenza-infected individuals the lack of vaccination in the current 275 season is associated with the enrichment of different microbial taxa, such as Moraxella 276
and Streptococcus, depending on the type of influenza virus (IAV vs IBV). Although we 277 cannot exclude or confirm that other confounding factors may also play a role in shaping 278 the nasopharyngeal microbiota of influenza-infected patients, we tested for factors that 279
were included in our demographic data, such as age, sex, and antibiotic usage, and did 280 not observe any other significant association. However, an aspect missing is how 281 vaccination can specifically reduce the risk for respiratory comorbidities, which can be 282 largely attributed to the disruption of the microbial community within the respiratory tract 283 (17). Because of an increased risk of infection, young and elderly populations get the 284 most benefit from influenza vaccination (35). We found that in the elderly group (65+), 285 the microbial diversity in the nasopharynx of unvaccinated patients was significantly 286 higher than in the vaccinated, with an overrepresentation of taxa that include pathogenic 287 species associated with nosocomial infections. A recent study has linked increased 288 nasopharynx microbial diversity with pneumonia infections in the elderly population (13). 289
While even an unmatched influenza vaccine can provide some level of cross-protection, 290 our findings suggest that a protective effect could also be mediated by modifications in 291 the microbiota that can help limit the growth of opportunistic pathogens. 292
293
Conclusion 294
Our aim in this study was to determine whether the microbiota of the nasopharynx was 295 different in individuals with influenza infection, and identify factors associated with the 296 variations observed between infected subjects in different age groups. We found that 297 during influenza infection, the nasopharyngeal microbiota of vaccinated individuals was 298 strongly associated with higher levels of specific microbial taxa, with different microbial 299 profiles relative to virus types and clade. These observations provide new insight into 300 influenza infection and highlight a need for more studies to explore the mechanism ofhow influenza vaccines-live-attenuated or killed-interact with the respiratory 302 microbiota. 303 304 305
Materials and Methods 306 307
Subjects and sample acquisition 308 Nasopharyngeal (NP) swabs collected from subjects of any age and sex that were sent 309 to the New York Presbyterian Hospital microbiology laboratory for influenza testing in 310 the 2014-2015 season were used for this study. All samples were confirmed by Film 311
Array (Biofire) to be either IAV H3N2 or IBV positive. Clinical data were abstracted from 312 the electronic medical record. For every subject we collected data on patient 313 demographics, comorbidities and related treatments, influenza vaccination history, 314 underlying malignancy status and treatments, antibiotics and antiviral treatments, 315 clinical course including infections and therapies, and microbiology data. We also 316 collected 80 NP swabs from 40 healthy patients living in New York City as controls. 317
These were enrolled as part of an IRB-approved study aiming to characterize the 318 respiratory microbiome in immunocompromised patients and healthy controls 319 (manuscript in preparation) ( Table S4) . These volunteers represented a mix of hospital 320 clinic workers and community members as we wanted to establish whether the hospital 321 environment contributed to the microbiota observed since a number of our patients were 322 hospitalized. We did not observe any difference between hospital workers and 323 community members. Total DNA and RNA were extracted from each sample and ThermoFisher Scientific Inc) was also processed through the same DNA extraction 334 procedure as the specimens and the healthy individual specimen control. Extracted 335 DNA was eluted in 50 µl nuclease-free water and stored at -20 °C until processing. 336
Extracted DNA was then used in a PCR reaction to amplify the V4 hypervariable region 337 of the 16S rRNA gene using primer pair 515F/806R to prepare the sequencing library 338 
16S rRNA gene sequence analysis 359
The sequencing data was processed using the 16S rRNA gene sequence curation 360 pipeline that was implemented in the mothur software package (37) following a 361 previously described procedure (38). Briefly, the raw sequences as fastq files were 362 extracted from sff files, and any sequence that had mismatches to the barcode, more 363 than one mismatch to the primers, more than 8 nucleotide homopolymers, or 364 ambiguous base calls was removed. Trimmed sequences were de-noised using 365 PyroNoise (39) and then aligned against a customized SILVA database (40). Chimaeric 366 sequences were detected and removed using a de novo Uchime algorithm that was 367 implemented in mothur (41). The De-chimaeric sequences were classified using the 368 naïve Bayesian Classifier trained against a customized version of the RDP training set 369 (v9). A minimum classification score of 80% was required and 1,000 pseudo-bootstrapiterations were used. The taxonomy of the remaining sequences was used to assign the 371 sequences to genus-level phylotypes, also known as operational taxonomic units (OTU), 372 and this allowed us to make a table of counts for the number of times each phylotype 373 was observed in each sample. Phylotypes that were identified in less than 20% of the 374 total samples were removed from subsequent analysis. Samples with fewer than 1,000 375 reads were removed from downstream analysis and all samples were sub-sampled or 376 rarified to 1,000 reads to perform subsequent analyses. Signature microbial groups 377 were identified by performing LEfSe (Linear discriminant analysis effective size) 378 analysis (41) implemented in mothur. Bacterial community types were defined using a 379 Dirichlet Multinomial Mixture (DMM) algorithm based method that was previously 380
described and implemented in mothur (42). Statistical tests, including Wilcoxon signed-381
rank test, chi-square test, and student t test were performed in R. 
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